This inventor holds 4 USPTO granted patents. Top assignee: Government of Republic of Singapore. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Yi Zhao: Innovator in Hepatitis B Research
Introduction
Yi Zhao is a prominent inventor based in Singapore, known for his significant contributions to the field of hepatitis B research. With a total of 4 patents, his work has advanced the understanding and treatment of this viral infection.
Latest Patents
Yi Zhao's latest patents include groundbreaking inventions related to mutant strains of the hepatitis B virus. One of his notable inventions is the "Mutant human hepatitis B viral strain and uses thereof." This invention provides an isolated strain of Hepatitis B virus designated Human Hepatitis B Virus Surface Antigen-'S'-133 Oon Strain, which has a unique amino acid sequence. The strain's viral genome is deposited under Accession Nos. P97121501, P97121502, and P97121503 with the European Collection of Cell Culture. Additionally, this invention offers various methods for using the disclosed isolated nucleic acid and peptides.
Another significant patent is the "Vaccine-induced hepatitis B viral strain and uses thereof." This invention presents an isolated strain of Hepatitis B virus designated Human Hepatitis B Virus Surface Antigen-'Ś-145 Singapore Strain. This strain also has a distinct amino acid sequence, with the amino acid at position number 145 being an arginine rather than a glycine. The viral genome for this strain is deposited under Accession Nos. P97121504, P97121505, and P97121506. This invention further provides various uses of the viral strain and its proteins.
Career Highlights
Yi Zhao works for the Government of the Republic of Singapore, where he applies his expertise in virology and molecular biology to develop innovative solutions for public health challenges. His research has been instrumental in advancing the understanding of hepatitis B and its implications for global health.
Collaborations
Yi Zhao has collaborated with notable colleagues, including Wei Chen and Chong Jin Oon, to further enhance the impact of his research in the field of hepatitis B.
Conclusion
Yi Zhao's contributions to hepatitis B research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of effective treatments and vaccines for hepatitis B, showcasing the importance of innovation in addressing public health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile